Displaying 1-2 of 2 result(s).
| Board Name | Posts By Hippcricket | Post Created |
|---|---|---|
| EA Electronic Arts Inc. | Why wouldn't this sell off to its 1 | 02/11/2016 9:32:29 AM |
| BABA Alibaba Group Holding Ltd | Baba expanding into online-travel | 01/05/2016 4:47:36 PM |
Recent Articles
- Univest Securities Completes $5 Million Offering for WORK Medical Tech
- Kura Oncology and Kyowa Kirin Unveil Ziftomenib Trial Findings
- Merus Showcases Promising Efficacy of Petosemtamab with Pembrolizumab
- Iovance Biotherapeutics Reveals 5-Year Study on Amtagvi® Efficacy
- Daktronics Engages at Leading Investor Conference This May
- Allogene Therapeutics Shares Key ASCO 2025 Abstracts on CAR T Developments
- IMUNON Seeks to Withdraw Registration Amid Growth Plans
- Abcourt Mines Inc. Reports Solid Third Quarter Progress
- PDS Biotech Shares Positive Results for Versamune® HPV Treatments
- Servotronics' Proxy Contest Conclusion and Upcoming Meeting
- Haivision to Unveil Financial Insights for Q2 Fiscal 2025
- M-tron Industries, Inc. Announces Upcoming Investor Meeting
- Rigel Pharmaceuticals Set for Major Presentations at ASCO 2025
- Investors Can Join Digimarc Corporation Class Action Today
- ImCheck Therapeutics Showcases Promising AML Therapy Results
- Legend Biotech Reveals Significant Updates in Cancer Treatment
- ROHM Introduces Next-Gen Compact NIR LEDs for Advanced Applications
- Cullinan Therapeutics and Partners Showcase Breakthrough Cancer Trial Findings
- Biodesix Unveils Promising Data on VeriStrat Test for NSCLC
- Acceleware Ltd. Achieves Significant Progress in Q1 2025
- Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting
- Petrus Resources Shares Success of Annual Meeting Outcomes
- Exciting Phase 2 Results from Actuate's Elraglusib in Cancer Treatment
- Candel Therapeutics Advances Localized Prostate Cancer Treatment
- Adagene Showcases Promising Results for ADG126 in Cancer Trials
- Banco Comercial Português Highlights Key AGM Resolutions
- Wheaton Precious Metals Unveils 2024 Reports on Sustainability and Climate
- Novita Reports Encouraging Phase 2 Trial Results for NP-G2-044
- Accent Therapeutics Showcases Innovative Cancer Treatment Advances
- Cizzle Bio's CIZ1B Test Offers Significant Medicare Savings
- Ontario International Airport Sees Record Passenger Growth
- Foresight Diagnostics Validates CLARITY MRD Assay for DLBCL
- XTANDI™ Breakthrough: Prostate Cancer Patients See 30% Survival Increase
- Servier Showcases Commitment to IDH-Mutated Cancer Research
- West Fraser Timber's Commitment to Sustainability in 2024
- Boehringer Ingelheim's Ambitious Plan for Future Cancer Innovations
- Taiho Oncology Unveils Groundbreaking Cancer Therapy Data
- Eli Lilly Unveils Research Presentations for ASCO 2025 Meeting
- COOFANDY Celebrates a Decade of Excellence with Major Awards
- Unlocking Earning Potential: FioBit's AI Mining Revolution 2025
- Unlock Passive Income with PAIRMiner's Cutting-Edge Mining
- THOR Industries Prepares for Upcoming Q3 2025 Earnings Call
- Clear Blue Technologies Plans Corporate Update and Q1 2025 Report
- Bicara Therapeutics Shares Key Data on Ficerafusp Alfa Therapy
- Northview Residential REIT Declares Latest Distribution for Investors
- Zymeworks Showcases Cancer Treatments at Major Medical Events
- VCI Global's Equity Agreement Revamped for Strategic Growth
- Innovative Treatment Combines Linvoseltamab with Proteasome Inhibitors
- Stephen Brannan Joins Serina Therapeutics Board for Growth
- Onconetix Inc. Faces Delisting Notice from Nasdaq Amid Compliance Issues